Abstract
dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmID) catalyzes the final step in the conversion of dTDP-D-glucose to dTDP-L-rhamnose in an NAD(P)H- and Mg2+-dependent reaction. L-rhamnose biosynthesis is an antibacterial target. The structure of RmID from Salmonella enterica serovar Typhimurium has been determined, and complexes with NADH, NADPH, and dTDP-L-rhamnose are reported. RmID differs from other short chain dehydrogenases in that it has a novel dimer interface that contains Mg2+. Enzyme catalysis involves hydride transfer from the nicotinamide ring of the cofactor to the C4'-carbonyl group of the substrate. The substrate is activated through protonation by a conserved tyrosine. NAD(P)H is bound in a solvent-exposed cleft, allowing facile replacement. We suggest a novel role for the conserved serine/threonine residue of the catalytic triad of SDR enzymes.
Original language | English |
---|---|
Pages (from-to) | 773-786 |
Number of pages | 14 |
Journal | Structure |
Volume | 10 |
Publication status | Published - Jun 2002 |
Keywords
- SDR
- reductase
- rhamnose
- NAD(P)H
- drug design
- Salmonella enterica serovar Typhimurium
- tuberculosis
- UDP-GALACTOSE 4-EPIMERASE
- ENTERICA SEROVAR TYPHIMURIUM
- CHAIN DEHYDROGENASE/REDUCTASE FAMILY
- L-RHAMNOSE PATHWAY
- CRYSTAL-STRUCTURE
- ESCHERICHIA-COLI
- CATALYTIC MECHANISM
- ACTIVE-SITE
- ENZYME
- DTDP